A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

NCT07219173 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

531

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Brenipatide
DRUG: Brenipatide
DRUG: Placebo

Sponsor

Eli Lilly and Company